Group Discussion for Guirguis Women’s Health
At Guirguis Women’s Health, we pride ourselves on delivering trusted OB/GYN care across Brooklyn and Staten Island—caring for every stage of women’s lives, from obstetrics to gynecological wellness (guirguiswomenshealth.com). Today, our group discussion centers on a rapidly growing innovation in women’s care: Point-of-Care Testing for Women Health.
According to Market Research Future, the Point-of-Care Testing for Women Health Market is projected to increase from approximately US$18.83 billion in 2025 to US$33.74 billion by 2035, reflecting a healthy CAGR of 6.26% Market Research Future. This surge is powered by rising prevalence of infectious diseases and infertility among women, along with a growing emphasis on accessible, rapid diagnostics Market Research Future.
For Guirguis Women’s Health, this presents an opportunity. Imagine providing patients with immediate testing for common concerns—like urinary tract infections, hormone levels, or reproductive indicators—right in the clinic. Not only could this reduce anxiety and waiting times, but it could also enhance clinical decision-making, personalize treatments, and build trust through efficiency.
Discussion prompts:
How might integrating point-of-care tests improve patient experience at our clinics? Have any team members seen this in action before?
Which tests would offer the most benefit—considering our patient needs and clinic operations?
What obstacles could arise (e.g., regulatory compliance, training, cost), and how might we overcome them?
This collaborative discussion aims to explore how integrating point-of-care diagnostics could elevate our standard of care—bringing speed, accuracy, and reassurance to women in our community. Your insights and experiences can help shape a more responsive and compassionate model for OB/GYN service delivery.